Evaluation of Implantable Tibial Neuromodulation Pivotal Study (TITAN 2)

NACompletedINTERVENTIONAL
Enrollment

188

Participants

Timeline

Start Date

January 31, 2022

Primary Completion Date

October 10, 2023

Study Completion Date

May 30, 2025

Conditions
Overactive Bladder
Interventions
DEVICE

Medtronic Implantable Tibial Neuromodulation (TNM) System

Stimulation of the tibial nerve using Medtronic's tibial neuromodulation device.

Trial Locations (29)

11794

Stony Brook University Hospital, Stony Brook

13210

Associated Medical Professionals, Syracuse

21204

Chesapeake Urology Associates, Towson

27403

Alliance Urology Specialists, Greensboro

28203

Atrium Health Carolinas Medical Center, Charlotte

28345

FirstHealth Urogynecology, Hamlet

29605

Prisma Health, Greenville

30120

Georgia Urology, Cartersville

35209

Urology Centers of Alabama, Homewood

43210

The Ohio State University Wexner Medical Center, Columbus

43230

Central Ohio Urology Group, Gahanna

45234

Wright State Physicians, Fairborn

46017

Urology Partners of North Texas Research Institute, Arlington

48084

Michigan Institute of Urology, Troy

48202

Henry Ford Health System, Detroit

49503

Mercy Health Saint Mary's, Grand Rapids

52242

University of Iowa Hospitals and Clinics, Iowa City

53211

Ascension Columbia St. Mary's, Milwaukee

55441

Minnesota Urology, Plymouth

55905

Mayo Clinic Urology, Rochester

57105

Sanford Female Pelvic Medicine & Reconstructive Surgery Clinic, Sioux Falls

60611

Northwestern Medicine, Chicago

60805

Providea Health Partners, Evergreen Park

70006

Louisiana State University Health Sciences Center, New Orleans

73120

Urology Surgeons of Oklahoma, Oklahoma City

77555

University of Texas Medical Branch, Galveston

98101

Virginia Mason Medical Center, Seattle

07631

Summit Health Englewood, Englewood

08043

Summit Health Voorhees, Voorhees Township

Sponsors

Lead Sponsor

All Listed Sponsors
lead

MedtronicNeuro

INDUSTRY